CSIMarket Company Name, Ticker, Competitors, else..
 
Alzamend Neuro Inc   (NASDAQ: ALZN)
 

ALZN's Market share relative to its competitors, as of Q1 2026

As of Q1 2026 (Revenue in Millions of $)

Date modified: 2026-07-18T11:00:09+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q1 2026		 MARKET SHARE
12 Months
Q1 2026		 MARKET SHARE
MRQ
Q1 2026		 MARKET SHARE
A Quarter Before
Q4 2025
Alzamend Neuro Inc 0.00 0.00% 0.00 % 0.00 %
Johnson and Johnson 96,362.00 23.89% 16.99% 17.62%
Eli Lilly And Company 79,665.80 19.75% 15.42% 14.50%
Pfizer Inc 63,315.00 15.70% 10.09% 10.58%
Sanofi 52,321.04 12.97% 12.97% 0.00%
Novartis Ag 51,722.00 12.82% 38.05% 37.88%
16 more competitors available

Sign in to see all competitors for Alzamend Neuro Inc .

Sign In Create Free Account



ALZN's Market share relative to its competitors, as of Q1 2026 within the Major Pharmaceutical Preparations Industry
As of Q1 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2026		 MARKET SHARE
12 Months Ending
Q4 2025		 MARKET SHARE
MRQ
Q1 2026		 MARKET SHARE

Q4 2025
Alzamend Neuro Inc 0.00% 0.00% 0.00 % 0.00 %
Johnson and Johnson 24.49% 25.61% 17.28% 17.92%
Eli Lilly And Company 20.25% 17.72% 15.69% 14.74%
Pfizer Inc 16.09% 17.01% 10.26% 10.76%
Sanofi 13.30% 13.49% 13.30% 13.49%
Novartis Ag 13.15% 12.69% 38.70% 38.52%
14 more companies available

Sign in to see all industry competitors for Alzamend Neuro Inc .

Sign In Create Free Account



ALZN's Market share relative to its competitors, as of Q1 2026 within the Healthcare Sector
As of Q1 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2026		 MARKET SHARE
12 Months Ending
Q4 2025		 MARKET SHARE
MRQ
Q1 2026		 MARKET SHARE

Q4 2025
Alzamend Neuro Inc 0.00% 0.00% 0.00 % 0.00 %
Johnson and Johnson 23.89% 24.94% 16.99% 17.62%
Eli Lilly And Company 19.75% 17.26% 15.42% 14.50%
Pfizer Inc 15.70% 16.57% 10.09% 10.58%
Sanofi 12.97% 13.13% 12.97% 13.13%
Novartis Ag 12.82% 12.35% 38.05% 37.88%
15 more companies available

Sign in to see all sector competitors for Alzamend Neuro Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Alzamend Neuro Inc's market divisions, geographic dispersion, segments, products, and services, visit Alzamend Neuro Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.